The global implications of diabetes and cancer

Affiliations

¹ Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; National Center for Anticancer Drugs Clinical Study, Beijing, China; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China. Electronic address: syuankai@cicams.ac.cn.
² Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Yuankai Shi et al. Lancet. 2014.

. 2014 Jun 7;383(9933):1947-8.

doi: 10.1016/S0140-6736(14)60886-2.

¹ Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; National Center for Anticancer Drugs Clinical Study, Beijing, China; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China. Electronic address: syuankai@cicams.ac.cn.
² Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

No abstract available

MeSH terms